Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis

INTRODUCTION: Angiogenesis is an important factor in the development of osteoarthritis (OA). We investigated the efficacy of bevacizumab, an antibody against vascular endothelial growth factor and an inhibitor of angiogenesis, in the treatment of OA using a rabbit model of anterior cruciate ligament...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Toshihiro, Sato, Masato, Kobayashi, Miyuki, Yokoyama, Munetaka, Tani, Yoshiki, Mochida, Joji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189677/
https://www.ncbi.nlm.nih.gov/pubmed/25230745
http://dx.doi.org/10.1186/s13075-014-0427-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189677/
https://www.ncbi.nlm.nih.gov/pubmed/25230745
http://dx.doi.org/10.1186/s13075-014-0427-y

Ejemplares similares